Navigation Links
Intercell Announces European Approval of New Vaccine, IXIARO(R), to Prevent Japanese Encephalitis
Date:4/2/2009

  • The immunogenicity was comparable to that of the U.S. licensed product, JE-VAX(R).
  • Intercell's vaccine demonstrated an overall clinical safety profile similar to placebo.
  • Further, Intercell's Japanese Encephalitis vaccine had a more favorable local tolerability profile in the head-to-head study with JE-VAX(R).

About Intercell AG

Intercell AG is an innovative biotechnology company that designs and develops novel vaccines for the prevention and treatment of infectious diseases with substantial unmet medical needs. Intercell's vaccine to prevent Japanese Encephalitis is the company's first product on the market.

The Company's technology platforms include an antigen-discovery system, adjuvants and a novel patch-based delivery system. Based on these technologies, Intercell has strategic partnerships with a number of global pharmaceutical companies, including Novartis, Merck & Co., Inc., Wyeth, Sanofi Pasteur, Kyowa Hakko Kirin and the Statens Serum Institut.

The Company's development pipeline includes Phase II vaccine programs for Pseudomonas (in-house development) and S. aureus, which is being developed with Merck & Co. Inc. The Company's novel Travelers' Diarrhea vaccine patch will enter Phase III testing in 2009. Intercell is also in clinical trials of a vaccine enhancement patch with injected Pandemic Influenza vaccines (one shot plus patch). In addition, four other products focused on infectious diseases are in pre-clinical development.

Intercell is listed on the Vienna stock exchange under the symbol "ICLL".

For more information, please visit: www.intercell.com

This communication expressly or implicitly contains certain forward-looking statements concerning Intercell AG a
'/>"/>

SOURCE Intercell AG
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Intercell to Host Conference Call and Webcast Today on FDA Approval of IXIARO(R) Japanese Encephalitis Vaccine
2. Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis
3. Australian Authorities (TGA) First to Grant Final Product Approval for Intercells Vaccine to Prevent Japanese Encephalitis
4. Iomai Stockholders Approve Merger With Intercell Subsidiary
5. Iomai, Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today
6. Nuevolution Announces Progress in Its Collaboration With Merck & Co. Inc.
7. China Biologic Products Announces Strong 2008 Results
8. Senetek PLC Announces New Investor Communication Hotline
9. NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
10. ACM Global Central Lab Announces Partnership with Chindexs United Family Hospitals in China
11. Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... June 17, 2013 The ALS Therapy Development Institute ... Tri-State Trek charity cycling event on July 19-21, 2013. The ... Newton, MA to Greenwich, CT ... (ALS, Lou Gehrig,s disease). (Logo: ... , the Tri-State Trek passes through 46 communities ...
(Date:6/17/2013)... June 17, 2013 VARTA ... batteries, has announced the opening of its new ... 12, Westchester County’s business community received an inside ... electric car and powered the camera Neil Armstrong ... an opening celebration showcasing VARTA’s many historic achievements ...
(Date:6/15/2013)... The topics that will be covered in ... scrum roles, scrum meetings, scrum artifacts, and scrum simulation ... PDUs) for attending them. , These trainings are suitable ... It is also ideal for those who will be ... software industry or those who want to explore Agile ...
(Date:6/14/2013)... The OpenClinica Global Conference is being ... with Formedix CEO, Mark Wheeldon presenting as part of ... deeper insight into the future developments at OpenClinica and ... to develop innovative solutions. , The conference program will ... hear real-life case studies and discover more about best ...
Breaking Biology Technology:ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 2ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 3VARTA Microbattery Celebrates New North American Headquarters in Rye, NY 2VARTA Microbattery Celebrates New North American Headquarters in Rye, NY 3VARTA Microbattery Celebrates New North American Headquarters in Rye, NY 4Affordable Scrum Trainings in Chicago on July 12th 2013 by Conscires Agile Practices 2Affordable Scrum Trainings in Chicago on July 12th 2013 by Conscires Agile Practices 3Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 2Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 3
... Mass., May 9 Millstone Medical Outsourcing,announced ... ISO 13485,certified quality system to the Memphis, ... the world,s largest developer and,publisher of international ... a highly-experienced quality engineer, to serve as ...
... 9 The International Center for Adult,Stem ... that,it has officially launched a global communications ... Spinal Cord Injury Symposium,Olfactory Mucosa Autografts (OMA) ... through May 10th in Argostolli, Kefalonia, Greece. ...
... announced financial results for the first quarter 2008. Novavax,reported a ... the first,quarter of 2008 compared to a net loss of ... 2007. Total cash and short-term investments,as of March 31, 2008 ... 2007. The cash burn for the quarter was $5.6 million., ...
Cached Biology Technology:Millstone Medical Outsourcing Achieves Quality Advantages in Memphis: Certified ISO 13485, Hires Experienced Quality Manager 2International Center for Adult Stem Cell Education Debuts at Spinal Cord Injury Symposium in Greece 2Novavax Reports First Quarter 2008 Financial Results 2Novavax Reports First Quarter 2008 Financial Results 3Novavax Reports First Quarter 2008 Financial Results 4Novavax Reports First Quarter 2008 Financial Results 5Novavax Reports First Quarter 2008 Financial Results 6Novavax Reports First Quarter 2008 Financial Results 7Novavax Reports First Quarter 2008 Financial Results 8
(Date:6/14/2013)... will collaborate with researchers from Oklahoma State University, ... of Tulsa to advance understanding of how socio-ecological ... and variability in the state. , Oklahoma ... $20 million National Science Foundation Experimental Program to ... innovative research over the next five years. ...
(Date:6/14/2013)... work carried out by the Carbohydrate Metabolism Research ... jointly owned by the NUP/UPNA-Public University of Navarre, ... Government of Navarre), the discovery has been made ... (now renamed as the "surface composition regulator", scoR) ... in bacterial infection can be altered by manipulating ...
(Date:6/14/2013)... week in the journal Science , Swedish and ... million year old fossil fishes, revealed by unique fossils ... help scientists to understand how neck muscles and abdominal ... naturally conjures up a vision of rattling skeletons. Bones ... and are usually the only traces of the animal ...
Breaking Biology News(10 mins):OU researchers collaborate on $20 million NSF EPSCoR grant 2OU researchers collaborate on $20 million NSF EPSCoR grant 3Discovery of how a gene that regulates factors involved in bacteria pathogenicity acts 2Discovery of how a gene that regulates factors involved in bacteria pathogenicity acts 3
... This release is available in Spanish . ... oldest persons in the world, who recently died at the ... which could have contributed to this longevity. The research team, ... pointed out a healthy lifestyle, a Mediterranean diet, a temperate ...
... may have an important role to play in the fate ... recent war campaigns, according to a new report in the ... Press. The researchers found evidence that fungi can ... less likely to find its way into plants, animals, or ...
... plague may be more virulent than their close relatives because ... the May issue of the journal Microbiology. The plague ... body temperature. When there is no calcium available, it produces ... said Professor Brubaker from the University of Chicago, USA. We ...
Cached Biology News:The secret to long life may not be in the genes 2Fungi have a hand in depleted uranium's environmental fate 2
... Serum • Cyno serum is collected off the clot ... years of age. Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium Oxalate ... N-05: ACD N-07: CPD N-09: ...
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
adult...
DNA Purification...
Biology Products: